Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex proteins. Improving these processes involves modifying various variables, including cell line engineering, media formulation, and bioreactor conditions. A key goal is to amplify antibody titer while lowering production costs and m